Updated Jul 16, 2026
Faller Douglas Vincent has filed 2 SEC Form 4 filings across 1 company in the last 90 days.

Douglas Vincent Faller is identified in SEC filings as the Chief Medical Officer of Imunon, Inc. as of June 29, 2026. The available SEC context confirms his role and affiliation but does not provide additional biographical details such as education, professional history, or prior positions. Based on the filings, he is a biotechnology executive serving in a senior medical leadership capacity with Imunon, Inc.
| Role | Chief Medical Officer |
|---|---|
| Notability | 45/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-07 | IMNN | Imunon, Inc. | A — Grant or award | 1.3K | $1.91 | $2K |
| 2026-06-29 | IMNN | Imunon, Inc. | A — Grant or award | 21.9K | $1.72 | $38K |
Douglas Vincent Faller is identified in SEC filings as the Chief Medical Officer of Imunon, Inc. as of June 29, 2026. The available SEC context confirms his role and affiliation but does not provide additional biographical details such as education, professional history, or prior positions. Based on the filings, he is a biotechnology executive serving in a senior medical leader…
2 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Faller Douglas Vincent profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.